Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis
Article in Frontiers in Oncology (November 2022)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
PEITC: A resounding molecule averts metastasis in breast cancer cells in vitro by regulating PKCδ/Aurora A interplay
Article in Heliyon (November 2022)
Mesoporous Silica Nanoparticles for Combined Delivery of Polo-Like Kinase 1 (PLK1) and Epidermal Growth Factor Receptor (EGFR) Inhibitors Enhances Radio Sensibility in Non-Small Cell Lung Cancer
Article in Science of Advanced Materials (October 2021)